The investigators are conducting a comparative effectiveness trial among adult patients with
sickle cell disease (SCD) who report chronic pain (N = 350), randomized to receive either
mobile phone-delivered computerized cognitive behavioral therapy (cCBT; n = 175) or digital
education (m-Education; n = 175). Both intervention groups will receive weekly (more frequent
if requested or needed) follow-up with a health coach for at least 3 months to reinforce
learned materials. Both groups will also use their mobile device to track daily pain, mood,
and medication used for two-week periods at baseline and each of the follow-up points (3, 6
and 12 months). Participants will also be given access to a study-associated online support
group page where members can discuss with other patients, issues participants faced and what
skills were or could be used to address them. Participants will continue all routine care
including opioid pain management and novel therapies.
| Laura De Castro, MD | |
| 412-648-6575 | |
| decastrolm@upmc.edu |
| Charles Jonassaint, PhD | |
| 412-586-9850 | |
| cjonassaint@pitt.edu |
5 United States sites
> 18 Years
N/A
Interventional
All
Other
Unknown
– People with any type of sickle cell disease
– Male or female, age 18 years or older
– Reports chronic pain: i.e pain more days that not for the past 3 months or longer
and/or is prescribed daily or long-acting opioids for pain.
– English speaking
– Any potential participants who fail consent comprehension questions